US- or Canada-based media Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the global Phase 2 WILLOW study (NCT05162586) ...

Although it did not meet the primary endpoint of dose-response relationship, when compared to placebo, enpatoran demonstrated improvements in measures of both systemic and cutaneous disease activity ...

Cohort B of the Phase 2 study indicates all doses of enpatoran were associated with higher BICLA response rates compared with placebo, though the ...

This unpredictable autoimmune disease presents unique challenges for people with it. This unpredictable autoimmune disease ...

Autoimmune thyroid disorders are common in lupus patients, but do not worsen disease outcomes, a new study finds. APS ...

An autoantibody associated with systemic lupus erythematosus may help improve the performance of immune checkpoint inhibitor ...

The guideline recommendations advise universal use of hydroxychloroquine, minimizing steroids, and earlier introduction of ...

Research findings increasingly indicate close associations between autoimmune thyroid disease and rheumatic disease.

The annual 10km Lupus Awareness Fun Walk took place on May 31 in Mamelodi. We Also Sparkle and Waratwa foundations held the ...

Autoimmune disease symptoms vary greatly depending on which part of the body is affected, but some common symptoms include ...

and about 20% of patients develop systemic lupus erythematosus(SLE). The patient usually comes with symptoms of purple plaques or nodules and oedematous skin, mainly around the acral regions of the ...

Objective To evaluate the risk of stroke and myocardial infarction (MI) in adult patients with systemic lupus erythematosus (SLE) through a systematic review and meta-analysis. Methods We searched ...